Inhibition of hyaluronan synthases decreases matrix metalloproteinase-7 (MMP-7) expression and activity

Surgery

Volumn 145, Issue 3, 2009, Pages 322-329

  Bullard Dunn, Kelli M ^a   Lee, Peter K ^b   Wilson, Christopher M ^b   Iida, Joji ^b   Wasiluk, Karen R ^b   Hugger, Marie ^b   McCarthy, James B ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONAN SYNTHASE 2; HYALURONAN SYNTHASE 3; ILOMASTAT; ISOENZYME; MATRIGEL; MATRILYSIN; SYNTHETASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CARCINOMA CELL; CELL ASSAY; COLON CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; COLLAGEN; COLORECTAL NEOPLASMS; DIPEPTIDES; DISEASE PROGRESSION; DNA, ANTISENSE; DRUG COMBINATIONS; GLUCURONOSYLTRANSFERASE; HUMANS; HYALURONIC ACID; LAMININ; MATRIX METALLOPROTEINASE 7; PROTEOGLYCANS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFECTION;

EID: 60149110672     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.11.008     Document Type: Article

References (51)

1. Knudson C., and Toole B. Changes in the pericellular matrix during differentiation of limb bud mesoderm. Devel Biol 112 (1985) 308-318
2. Shyjan A., Heldin P., Butcher E., Yoshino T., and Briskin M. Functional cloning of the cDNA for a human hyaluronan synthase. J Biol Chem 271 (1996) 23395-23399
3. Watanabe K., and Yamaguchi Y. Molecular identification of a putative human hyaluronan synthase. J Biol Chem 271 (1996) 22945-22948
4. Menzel E., and Farr C. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Lett 131 (1998) 3-11
5. Auvinen P., Tammi R., Parkkinen J., Tammi M., Agren U., Johansson R., et al. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 156 (2000) 529-536
6. Setälä L., Tammi M., Tammi R.H., Eskelinen M.J., Lipponen P.K., Agren U.M., et al. Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer 79 (1999) 1133-1138
7. Lovvorn H., Savani R., Ruchelli E., Cass D., and Adzick N. Serum hyaluronan and its association with unfavorable histology and aggressiveness of heterotransplanted Wilms' tumor. J Pediatr Surg 35 (2000) 1070-1078
8. Ropponen K., Tammi M., Parkkinen J., Eskelinen M., Tammi R., Lipponen P., et al. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 58 (1998) 342-347
9. Wang C., Tammi M., Guo H., and Tammi R. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am J Pathol 148 (1996) 1861-1869
10. Paiva P., Van Damme M.P., Tellbach M., Jones R.L., Jobling T., and Salamonsen L.A. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Gynecol Oncol 98 (2005) 193-202
11. Li Y., and Heldin P. Hyaluronan production increases the malignant properties of mesothelioma cells. Br J Cancer 85 (2001) 600-607
12. Kosaki R., Watanabe K., and Yamaguchi Y. Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage independent growth and tumorigenecity. Cancer Res 59 (1999) 1141-1145
13. Itano N., Sawai T., Miyaishi O., and Kimata K. Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res 59 (1999) 2499-2504
14. Simpson M., Wilson C., Furcht L., Spicer A., Oegema T., and McCarthy J. Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells. J Biol Chem 277 (2002) 10050-10057
15. Simpson M., Wilson C., and McCarthy J. Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Am J Pathol 161 (2002) 849-857
16. Bullard K.M., Kim H.R., Wheeler M.A., Wilson C.M., Neudauer C.L., Simpson M.A., et al. Hyaluronan synthase-3 is upregulated in metastatic colon carcinoma cells and manipulation of expression alters matrix retention and cellular growth. Int J Cancer 107 (2003) 739-746
17. Kim H.R., Wheeler M.A., Wilson C.M., Iida J., Eng D., Simpson M.A., et al. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res 64 (2004) 4569-4576
18. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaronson S.A., Kozlowski J.M., et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47 (1987) 3229-3245
19. Laurich C., Wheeler M., Iida J., Neudauer C., McCarthy J., and Bullard K. Hyaluronan mediates adhesion of metastatic colon carcinoma cells. J Surg Res 122 (2004) 70-74
20. Lynch C.C., and Matrisian L.M. Matrix metalloproteinases in tumor-host cell communication. Differentiation 70 (2002) 561-573
21. MacDougall J.R., Bani M.R., Lin Y., Rak J., and Kerbel R.S. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 55 (1995) 4174-4181
22. Davies B., Miles D.W., Happerfield L.C., Naylor M.S., Bobrow L.G., Rubens R.D., et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67 (1993) 1126-1131
23. Wolf C., Rouyer N., Lutz Y., Adida C., Loriot M., Bellocq J.P., et al. Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 90 (1993) 1843-1847
24. Murray G.I., Duncan M.E., O'Neil P., Melvin W.T., and Fothergill J.E. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 2 (1996) 461-462
25. Yamamoto H., Adachi Y., Itoh F., Iku S., Matsuno K., Kusano M., et al. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 59 (1999) 3313-3316
26. Adachi Y., Yamamoto H., Itoh F., Hinoda Y., Okada Y., and Imai K. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 45 (1999) 252-258
27. Collins H.M., Morris T.M., and Watson S.A. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase. Br J Cancer 84 (2001) 1664-1670
28. Elnemr A., Yonemura Y., Bandou E., Kinoshita K., Kawamura T., Takahashi S., et al. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer. Gastric Cancer 6 (2003) 30-38
29. Mori M., Barnard G.F., Mimori K., Ueo H., Akiyoshi T., and Sugimachi K. Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer 75 Suppl 6 (1995) 1516-1519
30. Shattuck-Brandt R.L., Lamps L.W., Heppner Goss K.J., DuBois R.N., and Matrisian L.M. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms. Mol Carcinog 24 (1999) 177-187
31. Witty J., McDonnell S., Newell K.J., Cannon P., Navre M., Tressler R.J., et al. Modulation of Matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 54 (1994) 4805-4812
32. Nagase H. Human stromelysins 1 and 2. Methods Enzymol 248 (1995) 449-470
33. Yu W.H., and Woessner Jr. J.F. Heparin-enhanced zymographic detection of matrilysin and collagenases. Anal Biochem 293 (2001) 38-42
34. Nakagawa T., Kubota T., Kabuto M., and Kodera T. Hyaluronic acid facilitates glioma cell invasion in vitro. Anticancer Res 16 (1996) 2917-2922
35. Radotra B., and McCormick D. Glioma invasion in vitro is mediated by CD44-hyaluronan interactions. J Pathol 181 (1997) 434-438
36. Monaghan M., Mulligan K.A., Gillespie H., Trimble A., Winter P., Johnston P.G., et al. Epidermal growth factor up-regulates CD44-dependent astrocytoma invasion in vitro. J Pathol 192 (2000) 519-525
37. Kobayashi H., Suzuki M., Kanayama N., Nishida T., Takigawa M., and Terao T. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells. Int J Cancer 102 (2002) 379-389
38. Powell W.C., Knox J.D., Navre M., Grogan T.M., Kittelson J., Nagle R.B., et al. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res 53 (1993) 417-422
39. Basset P., Bellocq J.P., Wolf C., Stoll I., Hutin P., Limacher J.M., et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348 (1990) 699-704
40. Heppner K.J., Matrisian L.M., Jensen R.A., and Rodgers W.H. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149 (1996) 273-282
41. McDonnell S., Navre M., Coffey Jr. R.J., and Matrisian L.M. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog 4 (1991) 527-533
42. Nagashima Y., Hasegawa S., Koshikawa N., Taki A., Ichikawa Y., Kitamura H., et al. Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors. Int J Cancer 72 (1997) 441-445
43. Newell K.J., Matrisian L.M., and Driman D.K. Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis. Mol Carcinog 34 (2002) 59-63
44. Matsuyama Y., Takao S., and Aikou T. Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. J Surg Oncol 80 (2002) 105-110
45. Ichikawa Y., Ishikawa T., Momiyama N., Yamaguchi S., Masui H., Hasegawa S., et al. Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin. Clin Exp Metastasis 16 (1998) 3-8
46. Momiyama N., Koshikawa N., Ishikawa T., Ichikawa Y., Hasegawa S., Nagashima Y., et al. Inhibitory effect of matrilysin antisense oligonucleotides on human colon cancer cell invasion in vitro. Mol Carcinog 22 (1998) 57-63
47. Zhang Y., Thant A.A., Machida K., Ichigotani Y., Naito Y., Hiraiwa Y., et al. Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90. Cancer Res 62 (2002) 3962-3965
48. Yu W.H., and Woessner Jr. J.F. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem 275 (2000) 4183-4191
49. Yu W.H., Woessner Jr. J.F., McNeish J.D., and Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 16 (2002) 307-323
50. Hulboy D.L., Gautam S., Fingleton B., and Matrisian L.M. The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse. Oncol Rep 12 (2004) 13-17
51. Kioi M., Yamamoto K., Higashi S., Koshikawa N., Fujita K., and Miyazaki K. Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model. Oncogene 22 (2003) 8662-8670